Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

103.63
-2.9900-2.80%
Volume:96.81K
Turnover:10.33M
Market Cap:5.80B
PE:-25.20
High:110.44
Open:107.69
Low:103.44
Close:106.62
52wk High:117.88
52wk Low:23.39
Shares:55.93M
Float Shares:55.85M
Volume Ratio:0.91
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1130
EPS(LYR):-4.2037
ROE:-26.07%
ROA:-17.69%
PB:4.95
PE(LYR):-24.65

Loading ...

Should Dianthus Therapeutics’ (DNTH) Big Cash Raise and LBL-047 Bet Prompt Investor Reassessment?

Simply Wall St.
·
May 11

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Tenax Therapeutics (TENX) and Compass Therapeutics (CMPX)

TIPRANKS
·
May 10

Dianthus Therapeutics (DNTH) Receives a Buy from Guggenheim

TIPRANKS
·
May 06

Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (JAZZ), Dianthus Therapeutics (DNTH) and Waters (WAT)

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
May 06

LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis

GlobeNewswire
·
May 06

Nanjing Leads Biolabs says LBL-047 Phase I trial starts in China for lupus

Reuters
·
May 06

Dianthus reports Q1 EPS (85c), consensus ($1.10)

TIPRANKS
·
May 06

Dianthus Q1 FY26 net loss widens 38.37% to $40.8 million

Reuters
·
May 06

Dianthus Therapeutics Inc Q1 Income From Operations USD -46.533 Million

THOMSON REUTERS
·
May 06

Press Release: Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results

Dow Jones
·
May 06

Dianthus Therapeutics grants inducement stock options for 135,000 shares at $87.42

Reuters
·
May 02

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 02

Dianthus treatment of myasthenia gravis gets orphan status

TIPRANKS
·
May 01

Dianthus Therapeutics (DNTH) Is Up 10.1% After $719M Raise And Insider Sale Has The Bull Case Changed?

Simply Wall St.
·
Apr 15

Dianthus CFO Ryan Savitz disposes 8,224 shares for $738,460

Reuters
·
Apr 11

Dianthus Therapeutics announces annual shareholder meeting notice

Reuters
·
Apr 10

Dianthus Therapeutics grants 135,000 inducement stock options to eight new hires

Reuters
·
Apr 07

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 07

Dianthus CFO Ryan Savitz disposes of DNTH common shares worth $9.1 million

Reuters
·
Apr 02